miR-147b is an oncomiR acting synergistically with HIPK2 to promote pancreatic carcinogenesis.

[1]  T. Saika,et al.  miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation , 2022, Scientific Reports.

[2]  Y. Miao,et al.  CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2 , 2022, Molecular cancer.

[3]  C. Kang,et al.  MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer , 2021, Cellular Oncology.

[4]  Lianghai Wang,et al.  Epigenetically associated CCL20 upregulation correlates with esophageal cancer progression and immune disorder. , 2021, Pathology, research and practice.

[5]  P. Zhou,et al.  Circular RNA hsa_circ_0000277 sequesters miR-4766-5p to upregulate LAMA1 and promote esophageal carcinoma progression , 2021, Cell Death & Disease.

[6]  Michael Q. Zhang,et al.  Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models , 2021, Clinical Cancer Research.

[7]  X. Bai,et al.  Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis , 2021, Aging.

[8]  Zhi-wei Wang,et al.  Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. , 2020, Seminars in cancer biology.

[9]  Ping Li,et al.  Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53 , 2020, Science China Life Sciences.

[10]  C. Peng,et al.  Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1 , 2020, Oncogene.

[11]  Q. Guo,et al.  Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database. , 2020, Cancer Biotherapy and Radiopharmaceuticals.

[12]  T. Starr,et al.  Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. , 2020, Gastroenterology.

[13]  C. Huang,et al.  MicroRNA-147 inhibits myocardial inflammation and apoptosis following myocardial infarction via targeting HIPK2. , 2020, European review for medical and pharmacological sciences.

[14]  Li Chen,et al.  P53/PANK1/miR‐107 signalling pathway spans the gap between metabolic reprogramming and insulin resistance induced by high‐fat diet , 2020, Journal of cellular and molecular medicine.

[15]  M. Diodoro,et al.  An Alternative Splice Variant of HIPK2 with Intron Retention Contributes to Cytokinesis , 2020, Cells.

[16]  Yuehan Feng,et al.  MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. , 2019, Gene.

[17]  H. McCarthy,et al.  MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators , 2019, BMC Cancer.

[18]  P. Chain,et al.  MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential , 2019, Genes.

[19]  Donglin Sun,et al.  LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR‐613 , 2019, Journal of cellular and molecular medicine.

[20]  Zeng Ye,et al.  Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein , 2019, Theranostics.

[21]  Xuejie Deng,et al.  MicroRNA-147b Promotes Proliferation and Invasion of Human Colorectal Cancer by Targeting RAS Oncogene Family (RAP2B) , 2019, Pathobiology.

[22]  B. Zhang,et al.  Homeodomain‐interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer , 2019, Cell proliferation.

[23]  C. Bult,et al.  miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma , 2019, Nature Metabolism.

[24]  M. Dong,et al.  Serine/arginine protein‐specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53 , 2019, The FEBS journal.

[25]  Jian Li,et al.  LncRNA TP73-AS1 sponges miR-141-3p to promote the migration and invasion of pancreatic cancer cells through the up-regulation of BDH2 , 2019, Bioscience reports.

[26]  A. Schally,et al.  P53, GHRH, inflammation and cancer , 2018, EBioMedicine.

[27]  Rick B. Vega,et al.  Sarcolipin Signaling Promotes Mitochondrial Biogenesis and Oxidative Metabolism in Skeletal Muscle , 2018, Cell reports.

[28]  D. Bartel.  Metazoan MicroRNAs , 2018, Cell.

[29]  K. Shirahige,et al.  ASBEL–TCF3 complex is required for the tumorigenicity of colorectal cancer cells , 2016, Proceedings of the National Academy of Sciences.

[30]  A. Gomez-Muñoz,et al.  Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells. , 2016, Biochemical pharmacology.

[31]  A. Fusco,et al.  HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity , 2015, Oncotarget.

[32]  L. Baldini,et al.  MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma , 2014, Journal of Clinical Pathology.

[33]  G. Dorn,et al.  Regulation of Cardiac MicroRNAs by Cardiac MicroRNAs , 2013, Circulation research.

[34]  G. D’Orazi,et al.  Updates on HIPK2: a resourceful oncosuppressor for clearing cancer , 2012, Journal of experimental & clinical cancer research : CR.

[35]  M. Zavoral,et al.  Molecular biology of pancreatic cancer. , 2011, World journal of gastroenterology.

[36]  D. Givol,et al.  Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells , 2010, Oncogene.

[37]  B. Baradaran,et al.  Dysregulation of key microRNAs in pancreatic cancer development. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  M. Álvarez-Mon,et al.  Flow cytometry enumeration of apoptotic cancer cells by apoptotic rate. , 2015, Methods in molecular biology.

[39]  G. Lin,et al.  Effects of EdU labeling on mesenchymal stem cells. , 2013, Cytotherapy.

[40]  T. Hong,et al.  miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1 , 2013, Angiogenesis.